MENA.GCC Thoracic Tumor Board — Adjuvant Therapy in Resectable Early NSCLC. A regional multidisciplinary tumor board discussion focused on real-world cases and evidence in early-stage non-small cell lung cancer.
Date: Tuesday, 28 July 2026 · Format: Zoom Webinar
Agenda:
• 7:30–7:35 pm — Introduction (Prof. Khalid Kattan)
• 7:35–7:45 pm — Case Presentation (Dr. Ahmed Alluhabi)
• 7:45–7:55 pm — Case Presentation (Prof. Hampig Khouri)
• 7:55–8:05 pm — Panel Discussion (Kattan, Mahrous, Alshereef, Alahmadi)
• 8:05–8:20 pm — Case Presentation (Dr. Abdelrhman Alghabban, KFSH-RUH)
• 8:20–8:30 pm — Case Presentation (Prof. Ahmed Magdy)
• 8:30–8:45 pm — Cases from Attendees & Panel Discussion
• 8:45–9:00 pm — Case Presentation (Dr. Mervat Mahrous)
• 9:00–9:10 pm — Case Presentation (Prof. Zineb Benbrahim)
• 9:10–9:25 pm — IO Adjuvant Therapy in Early NSCLC (Prof. Christian Grohe)
• 9:25–9:55 pm — Roche Satellite Symposium · Adjourn & Conclusion
Faculty: Prof. Khalid Kattan (Alfaisal University, Riyadh), Prof. Hampig Khouri (Saint Joseph University, Beirut), Dr. Mervat Mahrous (PMMH Riyadh), Dr. Ahmed Alshereef (Al Hada Military Hospital, Taif), Dr. Ahmed Alluhabi (KFSH-RC Jeddah; Chairman, Saudi Thoracic Oncology Society), Dr. Abdelrhman Alghabban (KFSH&RC Riyadh), Dr. Asrar Alahmadi (Ohio State University, James Cancer Center), Prof. Ahmed Magdy (Shifa Hospital, New Cairo; NCI Cairo University), Prof. Zineb Benbrahim (Hassan II University Hospital, Fez, Morocco), Prof. Christian Grohe (PMMH).
Supported by Roche · Organized with Alfaisal University · Managed by EventTroop.
